ArticleAnnals of hematology2023
Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study.
Jiapei Liu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleAnnals of hematology2023
Jiapei Liu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.